Ibrutinib Promising As First-Line Treatment in Older Patients with CLL

Ibrutinib Promising As First-Line Treatment in Older Patients with CLL

ASHReport

3 years
952 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Paul Barr, MD of University of Rochester, discusses how promising ibrutinib is as a first line treatment for older patients with CLL and comorbidities at the 58th ASH Annual Meeting in San Diego, CA.
Up Next Autoplay